Skip to main content

Table 3 Long-term outcomes of included studies

From: Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review

Author

Median DFS (months)

Median overall survival (months)

QOL outcomes

Portillaet al. [15]

 

20

.

Glehenet al. [25]

.

57.6 &

.

Bijelicet al. [26]

.

39

.

Bretcha-Boixet al. [27]

.

> 18 m

.

Cashinet al. [28]

 

23 (R 9–98)

.

Votanopouloset al. [29]

.

55.7 (R 0.3-110.2)

.

Chuaet al. [30]

.

23 (R 16.9–28.3)

.

Williamset al. [31]

 

22.6

.

Choudryet al. [23]

9.1 (R 3.9–14.3)

.

.

Jostet al. [32]

.

40 m (SD 12)

.

Lakset al. [24]

8.7 (R 1.2–26.3)

.

.

Paaschet al. [33]

 

R 16–87

.

Suttonet al. [18]

 

62.6 (R 25.3–99.9)

.

Valenzuelaet al. [34]

.

40.1

.

Pasqualet al. [35]

.

21 #

.

  1. DFS = disease free survival.
  2. QOL = quality of life.
  3. R = range.
  4. m = mean, SD = standard deviation.
  5. & = from initial CRS procedure.
  6. # calculated using Kaplan-Meier survival analysis